5 matches for your search in the start-up spotlight
rss
Stem cell expert recently founded a spin-off to further explore the potential of IPTOs for drug testing
13-Feb-2025
Scientists from the German Cancer Research Center (DKFZ) and ShanghaiTech University have developed an innovative method for growing brain tumors of individual patients in the laboratory that mimic the original structure and the molecular property of the parental tumor as closely as possible. ...
Focus on accelerated development of differentiated antibody-drug conjugates therapeutics for solid tumors
04-Apr-2023
BioNTech SE and Duality Biologics (Suzhou) Co. Ltd. (DualityBio), a clinical-stage biotech company focusing on the discovery and development of next generation antibody-drug conjugate (“ADC”) therapeutics to treat patients with cancer and autoimmune diseases, announced that the companies have ...
19-Jan-2022
NeoCura Bio-Medical Technology Co., Ltd., a RNA-based drug research and development company in China, and PhoreMost Limited, the UK-based biopharmaceutical company dedicated to ‘Drugging the Undruggable®’, announced an oncology drug discovery research collaboration As part of the collaboration, ...
Bota Bio’s next-generation industrial biology platform is a combination of computation and cutting-edge biotechnology
17-Mar-2021
BASF Venture Capital (BVC) has invested in Bota Biosciences, Ltd. (Bota Bio), an industrial synthetic biotech company based in Hangzhou, China. Bota Bio, founded in 2019, is developing a proprietary next-generation biotechnology platform which enables sustainable and economical production of high ...
06-Sep-2019
Evonik Venture Capital has invested in a 3D-printing start-up in China that makes implants for neuro and spine surgery. The technology enables faster recovery and fewer post-operation checks for patients and less surgical risk for doctors. Evonik is the lead investor in a high single-digit ...
